Company Financials

Vertex Pharmaceuticals Incorporated Financials

United States dollar

business Vertex Pharmaceuticals Incorporated Company Profile

Main Stock Listing

NASDAQ: VRTX

Market Capitalization $115.92 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 31.93
Forward PE 22.40
Price to Sales TTM $9.92
Price to Book MRQ $6.65
Enterprise to Revenue 9.43
Enterprise to EBITDA 23.47

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 31.35%
Operating Margin 40.27%
Return on Assets TTM 12.04%
Return on Equity TTM 22.31%

Income Statement

Revenue TTM $11,723,299,840
Revenue per Share TTM $45.68
Quarterly Revenue Growth 11.00%
Gross Profit TTM $6,180,100,096
EBITDA $485,800,000
Net Income to Common TTM $3,675,099,904
Diluted EPS TTM $14.20
Quarterly Earnings Growth YoY 3.60%

Balance Sheet

Total Cash MRQ $6,287,000,064
Total Cash per Share MRQ $24.78
Total Debt MRQ $
Total Debt to Equity MRQ 10.59
Current Ratio MRQ 2.36
Book Value per Share MRQ $68.20

Cash Flow

Operating Cash Flow TTM $3,718,000,128
Levered Free Cash Flow TTM $2,913,550,080

VRTX Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 253,951,475
Float Shares 252,957,675
Avg 10 Volume 1,235,810
Avg 30 Volume None
Shares Short 4,287,121
Short Ratio 3.08
Short % of Shares 1.91%
% Held by Insiders 0.13%
% Held by Institutions 97.47%

Stock Price Summary

Beta 0.32
Fifty Two Week Low $362.50
Fifty Two Week High $519.68
Fifty Two Week Change 9.96%
Day 50 MA $436.12
Day 200 MA $440.02

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date 2000-08-24